Oral Status and Prevalence of Dental Trauma in Children Treated With Ritalin Due to Attention-Deficit Hyperactivity Disorder (ADHD)

This study has been completed.

First Received: May 18, 2006 Last Updated: October 31, 2007 History of Changes

Sponsor:	Hadassah Medical Organization
Information provided by:	Hadassah Medical Organization
ClinicalTrials.gov Identifier:	NCT00328224

Purpose

To evaluate the dental status of children using ritalin and suffering from ADHA in comparison to healthy children.

Condition
Attention Deficit Disorder With Hyperactivity Dental Caries Dental Occlusion, Traumatic

Study Type:	Observational
Study Design:	Case Control
Official Title:	Oral Status and Prevalence of Dental Trauma in Children Treated With Ritalin Due to Attention-Deficit Hyperactivity Disorder (ADHD)

Resource links provided by NLM:

MedlinePlus related topics: Attention Deficit Hyperactivity Disorder Injuries Wounds

Drug Information available for: Methylphenidate Methylphenidate hydrochloride

U.S. FDA Resources

Further study details as provided by Hadassah Medical Organization:

Biospecimen Retention: None Retained

Biospecimen Description:

Enrollment:	50
Study Start Date:	May 2006
Study Completion Date:	October 2007

Detailed Description:

In this trial oral and dental status of 30 children (ages 5-12) who suffer from ADHD and treated with ritalin will be evaluated. Parameters that will be checked are the following: DMFT - decay, missing, filling teeth for dental status, GI - gingival index, PI - plaque index for periodontal status. OJ - over jet and OB - over bite for inter-maxillary relations and susceptibility for dental trauma. In addition these parameters will be collected for 30 age and sex match healthy children.

Eligibility

Ages Eligible for Study:	5 Years to 12 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	Yes
Sampling Method:	Probability Sample

Study Population

healthy children children with adhd treated with ritalin

Criteria

Inclusion Criteria:

children ages 5-12 years healthy children children taking ritalin who suffer from ADHD

Exclusion Criteria:

all others

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00328224

Locations

Israel
Hadassah Medical Organization, Jerusalem, Israel
Jerusalem, Israel, 91120

Sponsors and Collaborators

Hadassah Medical Organization

Investigators

Principal Investigator:	Diana Ram, DMD	Hadassah Medical Organization, Jerusalem, Israel
Study Director:	Meir Redlich, DMD,PhD	Hadassah Medical Organization, Jerusalem, Israel
Study Director:	Hadas Katz-Sagi, DMD	Hadassah Medical Organization, Jerusalem, Israel

More Information

No publications provided

Study ID Numbers:	230606-HMO-CTIL
Study First Received:	May 18, 2006
Last Updated:	October 31, 2007
ClinicalTrials.gov Identifier:	NCT00328224 History of Changes
Health Authority:	Israel: Israeli Health Ministry Pharmaceutical Administration

Keywords provided by Hadassah Medical Organization:

ritalin
ADHA
dental status

periodontal status
Attention-Deficit Hyperactivity Disorder
Dental trauma

Additional relevant MeSH terms:

Dopamine Uptake Inhibitors
Tooth Diseases
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Molecular Mechanisms of Pharmacological Action
Physiological Effects of Drugs
Methylphenidate
Dental Occlusion, Traumatic
Tooth Demineralization
Dental Caries
Signs and Symptoms
Pathologic Processes
Attention Deficit Disorder with Hyperactivity
Mental Disorders

Therapeutic Uses
Mental Disorders Diagnosed in Childhood
Hyperkinesis
Malocclusion
Disease
Nervous System Diseases
Attention Deficit and Disruptive Behavior Disorders
Central Nervous System Stimulants
Dyskinesias
Pharmacologic Actions
Neurologic Manifestations
Dopamine Agents
Stomatognathic Diseases
Central Nervous System Agents

ClinicalTrials.gov processed this record on February 08, 2010